Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis

Tongtong Ye(Weifang Medical University), Fang Han(Qilu Hospital of Shandong University)
Frontiers in Endocrinology
June 17, 2022
Cited by 32


Related Papers